Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Using bimodal MRI/fluorescence imaging to identify host angiogenic response to implants.

Berdichevski A, Simaan Yameen H, Dafni H, Neeman M, Seliktar D.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5147-52. doi: 10.1073/pnas.1502232112. Epub 2015 Mar 30.

2.

Protein composition alters in vivo resorption of PEG-based hydrogels as monitored by contrast-enhanced MRI.

Berdichevski A, Shachaf Y, Wechsler R, Seliktar D.

Biomaterials. 2015 Feb;42:1-10. doi: 10.1016/j.biomaterials.2014.11.015. Epub 2014 Dec 9.

PMID:
25542788
3.

Fabrication of PEGylated fibrinogen: a versatile injectable hydrogel biomaterial.

Mironi-Harpaz I, Berdichevski A, Seliktar D.

Methods Mol Biol. 2014;1181:61-8. doi: 10.1007/978-1-4939-1047-2_6.

PMID:
25070327
4.

TVP1022 protects neonatal rat ventricular myocytes against doxorubicin-induced functional derangements.

Berdichevski A, Meiry G, Milman F, Reiter I, Sedan O, Eliyahu S, Duffy HS, Youdim MB, Binah O.

J Pharmacol Exp Ther. 2010 Feb;332(2):413-20. doi: 10.1124/jpet.109.161158. Epub 2009 Nov 13.

5.

TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity.

Kleiner Y, Bar-Am O, Amit T, Berdichevski A, Liani E, Maor G, Reiter I, Youdim MB, Binah O.

J Cardiovasc Pharmacol. 2008 Sep;52(3):268-77. doi: 10.1097/FJC.0b013e3181862441.

PMID:
18806608

Supplemental Content

Loading ...
Support Center